−85.7927 USD
−23.53 M USD
0.00 USD
3.10 M
About Cingulate Inc.
Sector
CEO
Shane J. Schaffer
Headquarters
Kansas City
Website
Founded
2013
FIGI
BBG013YMVH68
Cingulate, Inc. operates as a clinical stage bio pharmaceutical company using Precision Timed Release, drug delivery platform technology to build a pipeline of next-generation pharmaceutical products. The firm initially focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). It identifies and evaluates additional therapeutic areas, PTR technology employed to develop future product candidates. Cingulate was founded by Shane J. Schaffer, Craig Steven Gilgallon, Raul R. Silva, Matthew N. Brams in 2013 and is headquartered in Kansas City, KS.
Displays a symbol's price movements over previous years to identify recurring trends.